Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
50mg |
|
||
100mg |
|
||
Other Sizes |
|
ln Vitro |
Nuclear factor I/CCAAT box transcription factor (NFI/CTF) is present in pirin, a nuclear protein. Pirin proteins are thought to be a member of the cupin superfamily because of their great degree of conservation among prokaryotes, plants, fungus, and mammals. The TPh A (20 μM; 5 hr) decreases the quantity of Bcl3 bound to pirin and hinders the interaction with glutathione S-transferase (GST) purLldown assay. HEK293T cells transfected with Myc and pirin-His6 vectors for 43 hours showed differences between pirin and Bcl3 [1]. While TPh A (0-100 μM; 48 hours) is active against MCF7, MDA-MB231, HeLa, DU145, HepG2, A549, HT1080, WM266-4, and SK, it lacks potent cytotoxic activity against many other human cancer cell lines. The IC50 values for MEL-28 cells are >50 μM, while those for PC3 HL60 and HT29 cells are 27 μM, 20 μM, and 26 μM, respectively [1]. WM266-4 and SK-MEL-28 cells' ability to migrate is inhibited by TPhA (0-50 μM; 48 hours) in a concentration-dependent manner [1].
|
---|---|
Cell Assay |
Cell Viability Assay[1]
Cell Types: MCF7, MDA-MB231, HeLa, DU145, HepG2, A549, HT1080, WM266-4, and SK-MEL-28 cells Tested Tested Concentrations: 0-100 μM Incubation Duration: 48 hrs (hours) Experimental Results: Did not exert any potent cytotoxic activity against many human cancer cell lines. |
References |
[1]. Isao Miyazaki, et al. A Small-Molecule Inhibitor Shows That Pirin Regulates Migration of Melanoma Cells. Nat Chem Biol. 2010 Sep;6(9):667-73.
|
Molecular Formula |
C21H21NO3S2
|
---|---|
Molecular Weight |
399.53
|
CAS # |
21306-65-0
|
Appearance |
Typically exists as solids (or liquids in special cases) at room temperature
|
SMILES |
CC1=CC=C(C=C1)S(=O)(=O)N=S(C)C2=CC=C(C=C2)OCC3=CC=CC=C3
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO: 250 mg/mL (625.74 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.21 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (5.21 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.08 mg/mL (5.21 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.5029 mL | 12.5147 mL | 25.0294 mL | |
5 mM | 0.5006 mL | 2.5029 mL | 5.0059 mL | |
10 mM | 0.2503 mL | 1.2515 mL | 2.5029 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.